Skip to main content
. 2022 Nov 23;13:1022598. doi: 10.3389/fimmu.2022.1022598

Figure 4.

Figure 4

Overview of putative neoantigens. (A) Analytic pipelines to output putative neoantigens. (B) The proportions of strong and weak binders in two groups. The two groups were categorized by the mutation rate >1% samples vs. <=1% samples.